Article
Effects of Polymorphisms in NR1H4, NR1I2, SLCO1B1, and ABCG2 on the Pharmacokinetics of Rosuvastatin in Healthy Chinese Volunteers.
Journal of cardiovascular pharmacology - 1 Nov 2016
Liu Mei, Wu Xiu-Jun, Zhao Gui-Lian, Zhang Ti, Xu Shan-Sen, Sun Ya-Xin, Qiu Feng, Zhao Li-Mei
Abstract excerpt
The nuclear receptors (NR)-farnesoid X receptor (FXR, NR1H4) and pregnane X receptor (PXR, NR1I2)-have important effects on the expression of genes related to the pharmacokinetics (PKs) of rosuvastatin. This study was designed to investigate whether the genetic variants in drug disposition genes (SLCO1B1 and ABCG2) combined with their upstream regulators (NR1H4 and NR1I2) would affect the PKs of rosuvastatin in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
